Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Suk Ryu

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Scientific Reports|August 30, 2023
Lateral interactions between CD276 and CD147 are essential for stemness in breast cancer: a novel insight from proximal proteome analysisYu Ri Seo, Junghyeon Lee, Han Suk Ryu, et al.
Human Pathology|May 26, 2015
Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtypeYul Ri Chung, Hyojin Kim, Soo Young Park, et al.
Breast Cancer Research and Treatment|April 28, 2019
Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patientsJung Youn Kim, Dae-Won Lee, Kyung-Hun Lee, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 9, 2021
JAK2 regulates paclitaxel resistance in triple negative breast cancersJongmin Han, Jihui Yun, Mingji Quan, et al.
Clinical & Experimental Metastasis|November 21, 2015
Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancerSoo Young Chung, Yoon Yang Jung, In Ae Park, et al.
Nature Communications|August 29, 2023
Barcoded multiple displacement amplification for high coverage sequencing in spatial genomicsJinhyun Kim, Sungsik Kim, Huiran Yeom, et al.
Journal of Cancer Research and Clinical Oncology|November 19, 2015
Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapyHyori Kim, Jeonghwan Youk, Yaewon Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Development and Validation of a Next-Generation Sequencing-Based Multigene Assay to Predict the Prognosis of Estrogen Receptor-Positive, HER2-Negative Breast CancerHan-Byoel Lee, Sae Byul Lee, Minsu Kim, et al.
Elife|March 24, 2023
Multi-targeted therapy resistance via drug-induced secretome fucosylationMark Borris D Aldonza, Junghwa Cha, Insung Yong, et al.
British Journal of Cancer|July 12, 2019
Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I-III breast cancer patientsDae-Won Lee, Han Suk Ryu, Min-Sun Jin, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Scientific Reports|August 30, 2023
Lateral interactions between CD276 and CD147 are essential for stemness in breast cancer: a novel insight from proximal proteome analysisYu Ri Seo, Junghyeon Lee, Han Suk Ryu, et al.
Human Pathology|May 26, 2015
Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtypeYul Ri Chung, Hyojin Kim, Soo Young Park, et al.
Breast Cancer Research and Treatment|April 28, 2019
Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patientsJung Youn Kim, Dae-Won Lee, Kyung-Hun Lee, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 9, 2021
JAK2 regulates paclitaxel resistance in triple negative breast cancersJongmin Han, Jihui Yun, Mingji Quan, et al.
Clinical & Experimental Metastasis|November 21, 2015
Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancerSoo Young Chung, Yoon Yang Jung, In Ae Park, et al.
Nature Communications|August 29, 2023
Barcoded multiple displacement amplification for high coverage sequencing in spatial genomicsJinhyun Kim, Sungsik Kim, Huiran Yeom, et al.
Journal of Cancer Research and Clinical Oncology|November 19, 2015
Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapyHyori Kim, Jeonghwan Youk, Yaewon Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Development and Validation of a Next-Generation Sequencing-Based Multigene Assay to Predict the Prognosis of Estrogen Receptor-Positive, HER2-Negative Breast CancerHan-Byoel Lee, Sae Byul Lee, Minsu Kim, et al.
Elife|March 24, 2023
Multi-targeted therapy resistance via drug-induced secretome fucosylationMark Borris D Aldonza, Junghwa Cha, Insung Yong, et al.
British Journal of Cancer|July 12, 2019
Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I-III breast cancer patientsDae-Won Lee, Han Suk Ryu, Min-Sun Jin, et al.
Pageof 15